OUR MOST POPULAR PEPTIDES
Premium research peptides, peptide stacks, and wellness formulations. Browse our collection and select the product that best suits your research needs.
-
Retatrutide
Regular price From R 2,400.00 ZARRegular priceSale price From R 2,400.00 ZAR -
Wolverine Stack
Regular price R 2,000.00 ZARRegular priceSale price R 2,000.00 ZAR -
GLOW-Stack
Regular price R 2,200.00 ZARRegular priceSale price R 2,200.00 ZAR -
KLOW-Stack
Regular price R 2,400.00 ZARRegular priceSale price R 2,400.00 ZAR -
NAD+ 1000mg Pen
Regular price R 1,800.00 ZARRegular priceSale price R 1,800.00 ZAR -
-
CJC-1295/Ipamorelin
Regular price R 1,600.00 ZARRegular priceSale price R 1,600.00 ZAR -
Meytrix Gift Card.
Regular price From R 250.00 ZARRegular priceSale price From R 250.00 ZAR -
PT-141 (bremelanotide)
Regular price R 800.00 ZARRegular priceSale price R 800.00 ZAR -
KISS-peptin
Regular price R 800.00 ZARRegular priceSale price R 800.00 ZAR -
BPC-157 (10MG)
Regular price R 650.00 ZARRegular priceSale price R 650.00 ZAR -
-
Reta Glow Stack - Retatrutide 30mg + GLOW Stack Bundle - Free Peptide Included
Regular price R 4,500.00 ZARRegular priceSale price R 4,500.00 ZAR -
Titan Stack - Wolverine Stack + Cjc-1295/Ipamorelin Bundle - Free Peptide Included
Regular price R 3,600.00 ZARRegular priceSale price R 3,600.00 ZAR -
MOTS-c Pre-Filled Pen 40Mg
Regular price R 2,200.00 ZARRegular priceSale price R 2,200.00 ZAR
BLOGS
View all-
GLP-1 Agonists Are Associated With a Significan...
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women Purpose Excess weight is a key modifiable risk factor for breast cancer. Glucagon-like peptide-1 receptor agonists...
GLP-1 Agonists Are Associated With a Significan...
GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women Purpose Excess weight is a key modifiable risk factor for breast cancer. Glucagon-like peptide-1 receptor agonists...
-
The GLP-1 Update for Women in Midlife: What’s C...
New research on GLP-1 medications, hormone therapy, visceral fat, metabolic disease, medication interactions, and what emerging treatments may mean for women in menopause.
The GLP-1 Update for Women in Midlife: What’s C...
New research on GLP-1 medications, hormone therapy, visceral fat, metabolic disease, medication interactions, and what emerging treatments may mean for women in menopause.
-
GLP-1 Medications and Menopause: What Current R...
As estrogen levels naturally decline during menopause, many women experience stubborn weight gain, increased abdominal fat, and metabolic changes. Learn how GLP-1 therapies may support healthier weight management during this...
GLP-1 Medications and Menopause: What Current R...
As estrogen levels naturally decline during menopause, many women experience stubborn weight gain, increased abdominal fat, and metabolic changes. Learn how GLP-1 therapies may support healthier weight management during this...
-
BPC-157 Dosage Guide
BPC-157 Dosage Guide How Much Should You Take for Recovery? BPC-157 has become one of the most widely discussed recovery peptides due to its potential role in supporting tendon, ligament,...
BPC-157 Dosage Guide
BPC-157 Dosage Guide How Much Should You Take for Recovery? BPC-157 has become one of the most widely discussed recovery peptides due to its potential role in supporting tendon, ligament,...
100% Quality Assured
Every Meytrix batch has undergone comprehensive analytical testing, including identity confirmation (MS), HPLC purity analysis, potency (assay), heavy metal screening, residual solvent analysis, water content verification and visual quality inspection.
Browse the COA menu to view batch-specific Certificates of Analysis.